Sean Gemmill serves as the Director of Regulatory Affairs for NeoGenomics’ Pharma Services division. He joined NeoGenomics in 2018 and has been working in the field of in-vitro diagnostics and medical device clinical & regulatory affairs for over 20 years. Mr. Gemmill provides regulatory affairs support for NeoGenomics companion diagnostic (CDx) programs and US-FDA submissions. He completed his BS degree in Health Sciences (1998) and a MS degree in Biomedical & Pharmaceutical Regulatory Affairs (2003), both from San Diego State University (San Diego, CA).
Director, Regulatory Affairs, Quality